Perioperative immunological response of Dai-Ken-Chu-Tou in colorectal cancer patients
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: Dai-Ken-Chu-Tou none Primary outcome(s): cytokines Study Design: Parallel Randomized
应用场景：
创建时间：
2010-01-15
相关数据集
Table1_Efficacy, Safety and Mechanism of Jinzhen Oral Liquid in the Treatment of Acute Bronchitis in Children: A Randomized, Double-Blind, Multicenter Clinical Trial Protocol.DOCX
Background: Acute bronchitis (AB) is a common disease in pediatrics. Prolonged AB may develop into chronic bronchitis. Bronchitis caused by the influenza virus can lead to severe hypoxia or insufficie
NIAID Data Ecosystem80
Table_1_Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Jinlida Granules on Metabolic Syndrome in Patients With Abnormal Glucose Metabolism.DOC
Background: Metabolic syndrome (MS) is a powerful risk factor for cardiovascular and cerebrovascular diseases. Although lifestyle intervention reduces several of the symptoms of the syndrome and cardi
NIAID Data Ecosystem40
Data Sheet 1_Formulation A in the prevention of rheumatoid arthritis: a study protocol for a multicenter randomized controlled trial.pdf
BackgroundInterventions to delay or prevent the onset of rheumatoid arthritis (RA) have attracted much attention in recent years. Researchers are now exploring various prevention strategies but no uni
NIAID Data Ecosystem20
Efficacy and Safety of Tangshen Formula on Patients with Type 2 Diabetic Kidney Disease: A Multicenter Double-Blinded Randomized Placebo-Controlled Trial
Background Persons with diabetes are at high risk of developing diabetic kidney disease (DKD), which is associated with high morbidity and mortality. Current drug therapies for DKD, such as angiotensi
NIAID Data Ecosystem50
Table1_Efficacy of Mudan Granule (Combined With Methylcobalamin) on Type 2 Diabetic Peripheral Neuropathy: Study Protocol for a Double-Blind, Randomized, Placebo-Controlled, Parallel-Arm, Multi-Center Trial.DOC
Background: Diabetic peripheral neuropathy (DPN) characterized by nerve damage is a common and disabling chronic microvascular complication in patients with type 2 diabetic mellitus (T2DM), affecting
NIAID Data Ecosystem30
